StreetAlpha.app
Home › Stocks › DRUG

Bright Minds Biosciences Inc. (DRUG)

$20.51
▼ −9.29%
LAST CLOSE · NOV 17

Bright Minds Biosciences Inc. (DRUG) tracked by StreetAlpha. It last closed at $20.51 on Nov 17, down 9.29% on the day. DRUG reports earnings on Tue, Dec 22, 2026. The average 12-month price target from 3 analysts is $98.00 (+377.8% from the last close), with a high of $150.00 and a low of $37.00. Analyst consensus is Strong Buy, based on the latest ratings from 3 firms (3 buy, 0 hold, 0 sell).

AI Auto Pilots
Is DRUG in one of our four AI portfolios? Sign in free to see
Next report
Dec 22
2026 · Time not announced
Consensus EPS forecast
-$1.07
 
Year-ago EPS
—
Not on file
Options-implied move
—
Posted about a week before
Analyst consensus
Strong Buy
Based on 3 analyst ratings (90 days)
Loading…

Analyst Ratings & Price Targets

Analyst Ratings →
Consensus · 90 days
Strong Buy
3firms
3 Buy0 Hold0 Sell
Each firm's latest rating on DRUG in the past 90 days
Average 12-month target
$98.00
▲ 377.8% upside

Based on 3 analysts who set a price target on DRUG in the past 90 days. The average target is $98.00, with a high of $150.00 and a low of $37.00, compared with the last close of $20.51.

Low $37.00Avg $98.00High $150.00
Blue marker: last close $20.51
Highest target$150.00
Average target$98.00
Lowest target$37.00
Latest rating changes
BairdMaintained
Nov 3Buy$107
BTIGTarget lowered
Nov 3Buy$147 → $37
Wolfe ResearchInitiated
Oct 15Buy$150
HC Wainwright & Co.Reiterated
Aug 19Buy$145
BTIGReiterated
Aug 17Buy$147
DateFirmActionRatingPrice target
Nov 3BairdMaintainedBuy$107
Nov 3BTIGTarget loweredBuy$147 → $37
Oct 15Wolfe ResearchInitiatedBuy$150
Aug 19HC Wainwright & Co.ReiteratedBuy$145
Aug 17BTIGReiteratedBuy$147
Loading…

Technical Analysis

DRUG · as of the Nov 17 close · updated after every close
Downtrend, oversold

The stock is 70% below its 20 day and 130% below its 50 day average. It is 239% below its 200 day average, so the longer trend is down. Momentum is weak (RSI 27), oversold. The nearest support is the Pivot S1 at $19.42, and the nearest resistance the Pivot at $20.95.

Short trendBearish
Long trendBearish
MomentumWeak
StretchOversold
VolatilityHigh, 20.1%/day
Key levels
$123.7552 week high+503.4%
$69.54200 day average+239.1%
$60.81100 day average+196.5%
$47.1450 day average+129.8%
$34.8620 day average+70.0%
$24.99Swing high (Nov 10)+21.8%
$22.04Pivot R1+7.5%
$20.95Pivot+2.1%
$20.51Last close
$19.42Pivot S1−5.3%
$17.4052 week low−15.2%
$17.40Swing low (Nov 5)−15.2%
Indicators
RSI (14)26.54Oversold below 30Oversold
MACD-8.65Below its signal lineBearish
Stochastic11.6Near the bottom of its rangeOversold
ADX (14)43.6Strong downtrend
Williams %R-92.3Oversold below −80, overbought above −20Oversold
CCI (20)-62.3Oversold below −100, overbought above 100Neutral
Rate of change−4.8%Change over 10 sessionsBearish
ATR (14)$4.13Typical daily range, 20.1% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
What happened before, for DRUG

What happened before

See how DRUG did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.

November seasonalityHow DRUG usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

Seasonality

How DRUG has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2021.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D

No whale options trades in DRUG in the last 90 days.

Loading…

See today’s whale options flow across the market →

DRUG Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Neutral
Strongly bearishNeutralStrongly bullish
  • ●45 buying vs 46 selling
  • ▼Shares held by funds -3.4%
  • ▲Funds holding +10
  • ▲Superinvestors: 2 added, 1 cut
  • ●Put/call not meaningful
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holding
Q3 2026This quarterLast quarterChange
Funds holding110100+10.0%
In funds' top 1012−50.0%
Held by funds–––
New / increased17 / 2819 / 47−31.8%
Reduced / sold out38 / 817 / 12+58.6%
Put/call ratio–––
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See DRUG institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

AI Auto Pilots

Paper trading

StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether DRUG is in one of them and how their past DRUG trades turned out.

DRUG in the AI portfolios
Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered DRUG in an article yet. Here's the latest on the wider market.